Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K
Preventive Healthcare Services01:30

Preventive Healthcare Services

967
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
967

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.

Future oncology (London, England)·2026
Same author

Prenatal Cell-Free DNA Screening With Fetal Fraction Amplification at 6-9 Weeks of Gestation.

Obstetrics and gynecology·2026
Same author

Results of breast cancer risk assessment and hereditary cancer genetic testing in community obstetrics and gynaecology practice following a prospective quality Improvement initiative.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2026
Same author

Optimizing Hereditary Cancer Risk Assessment and Genetic Testing Workflow in Interprofessional Women's Health Practice: A Multicenter Survey of Advanced Practice Providers.

Journal of midwifery & women's health·2026
Same author

Outcomes and Management of Pregnancies Screening Positive for Microdeletions 22q11.2, 15q11.2, 1p36, 4p, or 5p: A Retrospective Cohort Study.

The application of clinical genetics·2026
Same author

Cancer Risk Assessment and Hereditary Cancer Genetic Testing in a Community OBGYN Setting.

European journal of breast health·2026

Related Experiment Video

Updated: Jun 5, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K

Online Screening and Virtual Patient Education for Hereditary Cancer Risk Assessment and Testing.

Richard N Waldman1, Mark S DeFrancesco, John P Feltz

  • 1Associates for Women's Medicine, North Syracuse, New York; Women's Health Connecticut, Waterbury, and Women's Health Connecticut, Manchester, Connecticut; Lifeline Medical Associates, The Women's Care Source, Morristown, New Jersey; Associates for Women's Health Services of Central VA, Inc, Lynchburg, Virginia; and Myriad Genetics Inc, Salt Lake City, Utah.

Obstetrics and Gynecology
|December 5, 2024
PubMed
Summary
This summary is machine-generated.

Online screening and virtual education tools significantly improved hereditary cancer risk assessment, increasing genetic testing completion rates. These digital resources enhanced patient understanding and clinician efficiency in identifying at-risk individuals.

More Related Videos

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

10.8K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.2K

Related Experiment Videos

Last Updated: Jun 5, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K
Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

10.8K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.2K

Area of Science:

  • Oncology
  • Genetics
  • Digital Health
  • Preventive Medicine

Background:

  • Hereditary cancer risk assessment is crucial for early detection and prevention.
  • Traditional methods for risk assessment and patient education can be time-consuming and may not reach all eligible patients.
  • Improving access to and understanding of genetic testing is essential for effective cancer risk management.

Purpose of the Study:

  • To evaluate the effectiveness of online screening and virtual patient education tools in enhancing hereditary cancer risk assessment.
  • To determine the impact of these digital tools on genetic testing uptake and completion rates.
  • To assess clinician and patient satisfaction with the implemented tools.

Main Methods:

  • A prospective, single-arm study involving clinicians in five U.S. obstetrics and gynecology practices.
  • Implementation of an 8-week training period on online screening and virtual patient education tools.
  • Comparison of hereditary cancer risk assessment and patient education metrics before and after intervention, with a focus on genetic testing completion rates.

Main Results:

  • The proportion of screened patients meeting testing guidelines increased from 21.6% to 28.2%.
  • Guideline-eligible patients were significantly more likely to be offered genetic testing (89.1%), submit a sample (45.0%), and complete testing (34.2%).
  • High clinician and patient satisfaction reported, with tools improving identification of eligible candidates and patient understanding of genetic testing.

Conclusions:

  • A guideline-based online patient screening tool and virtual patient education are well-received and effective.
  • These digital tools significantly increase the identification of candidates for hereditary cancer risk assessment.
  • The intervention successfully improved patients' genetic literacy and ultimately enhanced the genetic testing completion rate.